PriceTargets.com logo

Oxford Nanopore Technologies - ONTTF Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $473.80
  • Forecasted Upside: 17,448.15%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.70 As of 03/30/2023 01:00 AM ET
▲ +0.2 (8.00%)

This chart shows the closing price for ONTTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oxford Nanopore Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONTTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONTTF

Analyst Price Target is $473.80
▲ +17,448.15% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Oxford Nanopore Technologies in the last 3 months. The average price target is $473.80, with a high forecast of $650.00 and a low forecast of $390.00. The average price target represents a 17,448.15% upside from the last price of $2.70.

This chart shows the closing price for ONTTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 1 polled investment analysts is to sell stock in Oxford Nanopore Technologies. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/3/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/23/2023JPMorgan Chase & Co.Lower TargetGBX 460 ➝ GBX 390
3/17/2023Peel HuntInitiated CoverageReduce
2/13/2023Berenberg BankLower TargetGBX 671 ➝ GBX 529
2/7/2023BarclaysLower TargetGBX 420 ➝ GBX 400
1/3/2023JPMorgan Chase & Co.Lower TargetGBX 720 ➝ GBX 460
9/25/2022Piper SandlerLower TargetGBX 750 ➝ GBX 650
9/14/2022JPMorgan Chase & Co.Boost TargetGBX 710 ➝ GBX 720
8/23/2022BarclaysLower TargetGBX 500 ➝ GBX 420
5/31/2022BarclaysLower TargetGBX 700 ➝ GBX 500
4/29/2022Royal Bank of CanadaLower TargetGBX 700 ➝ GBX 400
3/29/2022JPMorgan Chase & Co.Lower TargetGBX 790 ➝ GBX 710
3/17/2022CitigroupUpgradeNeutral ➝ Buy
3/2/2022Piper SandlerInitiated CoverageOverweight
(Data available from 3/30/2018 forward)

News Sentiment Rating

-0.48 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2023

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Oxford Nanopore Technologies logo
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
Read More

Today's Range

Now: $2.70
Low: $2.59
High: $2.70

50 Day Range

MA: $2.71
Low: $2.21
High: $3.20

52 Week Range

Now: $2.70
Low: $2.20
High: $5.30

Volume

1,602 shs

Average Volume

12,622 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Nanopore Technologies?

The following Wall Street analysts have issued stock ratings on Oxford Nanopore Technologies in the last twelve months: Barclays PLC, Berenberg Bank, JPMorgan Chase & Co., Peel Hunt, Piper Sandler, and Royal Bank of Canada.
View the latest analyst ratings for ONTTF.

What is the current price target for Oxford Nanopore Technologies?

5 Wall Street analysts have set twelve-month price targets for Oxford Nanopore Technologies in the last year. Their average twelve-month price target is $473.80, suggesting a possible upside of 17,448.1%. Piper Sandler has the highest price target set, predicting ONTTF will reach $650.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $390.00 for Oxford Nanopore Technologies in the next year.
View the latest price targets for ONTTF.

What is the current consensus analyst rating for Oxford Nanopore Technologies?

Oxford Nanopore Technologies currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ONTTF will underperform the market and that investors should sell shares of Oxford Nanopore Technologies.
View the latest ratings for ONTTF.

What other companies compete with Oxford Nanopore Technologies?

Other companies that are similar to Oxford Nanopore Technologies include 3SBio, Abattis Bioceuticals, Abcam, Adocia and Ainos. Learn More about companies similar to Oxford Nanopore Technologies.

How do I contact Oxford Nanopore Technologies' investor relations team?

Oxford Nanopore Technologies' physical mailing address is Gosling Building Edmund Halley Road Oxford Science Park Oxford OX4 4DQ United Kingdom. The company's listed phone number is 44 84 5034 7900. The official website for Oxford Nanopore Technologies is nanoporetech.com. Learn More about contacing Oxford Nanopore Technologies investor relations.